A detailed history of Kendall Capital Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Kendall Capital Management holds 3,120 shares of MEDP stock, worth $969,165. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,120
Previous 3,215 2.95%
Holding current value
$969,165
Previous $1.32 Million 21.45%
% of portfolio
0.33%
Previous 0.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$320.58 - $457.29 $30,455 - $43,442
-95 Reduced 2.95%
3,120 $1.04 Million
Q2 2024

Aug 12, 2024

SELL
$372.0 - $424.34 $83,700 - $95,476
-225 Reduced 6.54%
3,215 $1.32 Million
Q1 2024

May 10, 2024

SELL
$284.87 - $413.31 $31,620 - $45,877
-111 Reduced 3.13%
3,440 $1.39 Million
Q4 2023

Jan 26, 2024

SELL
$227.52 - $312.68 $45,276 - $62,223
-199 Reduced 5.31%
3,551 $1.09 Million
Q3 2023

Oct 31, 2023

SELL
$233.98 - $281.67 $156,766 - $188,718
-670 Reduced 15.16%
3,750 $908,000
Q4 2022

Jan 30, 2023

SELL
$153.06 - $226.57 $3,826 - $5,664
-25 Reduced 0.56%
4,420 $939,000
Q4 2021

Jan 28, 2022

SELL
$182.74 - $227.9 $64,872 - $80,904
-355 Reduced 7.4%
4,445 $967,000
Q3 2021

Nov 05, 2021

SELL
$170.18 - $198.21 $34,036 - $39,642
-200 Reduced 4.0%
4,800 $909,000
Q2 2021

Jul 30, 2021

SELL
$158.62 - $194.3 $39,655 - $48,575
-250 Reduced 4.76%
5,000 $883,000
Q1 2021

May 05, 2021

BUY
$132.02 - $168.26 $25,083 - $31,969
190 Added 3.75%
5,250 $861,000
Q4 2020

Feb 08, 2021

SELL
$109.38 - $149.19 $546 - $745
-5 Reduced 0.1%
5,060 $704,000
Q3 2020

Oct 22, 2020

BUY
$92.95 - $130.61 $57,629 - $80,978
620 Added 13.95%
5,065 $566,000
Q2 2020

Jul 30, 2020

BUY
$68.08 - $95.68 $95,992 - $134,908
1,410 Added 46.46%
4,445 $413,000
Q1 2020

Apr 27, 2020

BUY
$61.71 - $101.95 $187,289 - $309,418
3,035 New
3,035 $223,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.